Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis
Public ClinicalTrials.gov record NCT02950922. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center, randomized, vehicle-controlled, double-blind Phase 2 study in adults and adolescent subjects with mild to moderate atopic dermatitis.
Study identification
- NCT ID
- NCT02950922
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 157 participants
Conditions and interventions
Conditions
Interventions
- RVT-501 0.2% ointment Drug
- RVT-501 0.5% ointment Drug
- Vehicle ointment Other
Drug · Other
Eligibility (public fields only)
- Age range
- 12 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2016
- Primary completion
- Jul 2, 2017
- Completion
- Jul 2, 2017
- Last update posted
- Aug 5, 2018
2016 – 2017
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dermavant Investigator Site | Fremont | California | 94538 | — |
| Dermavant Investigator Site | Los Angeles | California | 90045 | — |
| Dermavant Investigator Site | San Diego | California | 92123 | — |
| Dermavant Investigator Site | San Luis Obispo | California | 93405 | — |
| Dermavant Investigator Site | Louisville | Kentucky | 40202 | — |
| Dermavant Investigator Site | Louisville | Kentucky | 40217 | — |
| Dermavant Investigator Site | Berlin | New Jersey | 08009 | — |
| Dermavant Investigator Site | Portland | Oregon | 97223 | — |
| Dermavant Investigator Site | Portland | Oregon | 97239 | — |
| Dermavant Investigator Site | Hershey | Pennsylvania | 17022 | — |
| Dermavant Investigator Site | Johnston | Rhode Island | 02919 | — |
| Dermavant Investigational Site | Dallas | Texas | 75230 | — |
| Dermavant Investigator Site | Houston | Texas | 77004 | — |
| Dermavant Investigator Site | Houston | Texas | 77030 | — |
| Dermavant Investigator Site | San Antonio | Texas | 78213 | — |
| Dermavant Investigator Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02950922, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2018 · Synced Sep 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02950922 live on ClinicalTrials.gov.